The two prices, and which one is yours
List price (wholesale acquisition cost, WAC) is what the manufacturer charges wholesalers; it drives insurance negotiations and the sticker at a pharmacy counter without coverage. Self-pay is the direct-to-patient price through the manufacturer's own pharmacy program (NovoCare for Novo Nordisk, LillyDirect for Lilly), also available through participating pharmacies and telehealth programs. The GLP-1 cost calculator totals these self-pay prices over the months you choose, with any program fee kept as a separate line, and our Costco guide compares one participating pharmacy's member prices with Novo's, dose by dose. If you have no coverage for the drug, self-pay is your price. If you have commercial coverage, the savings card is. Government coverage (Medicare, Medicaid, VA, TRICARE) excludes you from savings cards; see the coverage guide for what applies instead.
Wegovy, from Novo Nordisk's April 2026 price guide
| Product and dose | Self-pay per month | Condition |
|---|---|---|
| Wegovy tablets 1.5 mg | $149 | One bottle of 30 tablets |
| Wegovy tablets 4 mg | $149, then $199 | $149 offer ends 2026-08-31 |
| Wegovy tablets 9 mg and 25 mg | $299 | |
| Wegovy pen 0.25 mg and 0.5 mg | $199, then $349 | New patients, first two monthly fills, offer through 2026-12-31 |
| Wegovy pen 1 mg, 1.7 mg, 2.4 mg | $349 | One box of 4 pens |
| Wegovy HD pen 7.2 mg | $399 |
List price for the Wegovy pill, pen and HD pen is $1,349.02 per package. On February 24, 2026 Novo Nordisk announced that on January 1, 2027 the list price of Wegovy 2.4 mg injection and 25 mg tablets falls to $675, a change the company said does not affect self-pay prices.
Zepbound, Foundayo and Mounjaro, from LillyDirect
| Product and dose | Self-pay per month | Condition |
|---|---|---|
| Zepbound 2.5 mg (starting dose) | $299 | KwikPen or 4 single-dose vials; month = 28 days |
| Zepbound 5 mg | $399 | |
| Zepbound 7.5 mg | $449, else $499 | $449 only if refilled within 45 days of the last delivery |
| Zepbound 10, 12.5, 15 mg | $449, else $699 | Same 45-day condition |
| Foundayo 0.8 mg | $149 | Month = 30 days |
| Foundayo 2.5 mg | $199 | |
| Foundayo 5.5 mg and 9 mg | $299 | |
| Foundayo 14.5 mg and 17.2 mg | $299, else $349 | 45-day refill condition |
| Mounjaro, all doses | $499 | Single-dose pen |
Lilly's list-price pages give Zepbound as $499 to $1,086.37 per fill and Mounjaro as $1,112.16 (WAC as of January 1, 2026), and Foundayo as $649 for a 30-day supply. Zepbound's regular direct-to-patient prices without the refill program are $299, $399, $499, $699, $699 and $699 by dose.
If you have commercial insurance that covers the drug
Novo's Wegovy Savings Offer: pay as little as $25 for a one-month fill of the pen or tablets, with a maximum saving of $100 per month ($200 for two months, $300 for three). Lilly's Zepbound Savings Card: as little as $25 for up to a three-month fill of the single-dose pen, maximum $100 per month and $1,300 per calendar year, up to 13 fills, expiring December 31, 2026. If your commercial plan does not cover Zepbound, the card brings the single-dose pen to $499 and the KwikPen to $299 to $449 by dose. Both programs exclude anyone on Medicare, Medicaid, VA, DoD or TRICARE coverage.
TrumpRx.gov
TrumpRx.gov, launched February 5, 2026, lists Wegovy pill $149, Wegovy pen $199, Ozempic $199 and Zepbound $299 as its headline monthly prices, with the same offer text as the manufacturers (Wegovy pen $199 for two fills then $349; Ozempic $199 for two fills then $349, or $499 for 2 mg) and routes Zepbound, Foundayo and Mounjaro orders to LillyDirect. It is a directory to the manufacturer programs above, not a lower price.
Patient-assistance programs
Neither manufacturer's charity program covers its weight-loss GLP-1 today. Novo Nordisk's Patient Assistance Program product list for 2026 includes Ozempic (for uninsured patients only) but not Wegovy, Saxenda, Rybelsus or Victoza; Lilly Cares lists Trulicity as its only GLP-1 and does not include Zepbound, Mounjaro or Foundayo.
The arithmetic that matters
Doses escalate, so a year is not twelve times the starting price. A Zepbound patient who reaches a maintenance dose pays $449 a month on the refill program, about $5,400 a year, or up to $8,400 if the 45-day condition lapses; a Wegovy pen patient pays $349 after the two-month offer, about $4,100 in the first year; Wegovy tablets at 25 mg run $299, about $3,600. Compounded programs advertise less, and sell a product the FDA has not reviewed; that trade-off is set out in our explainer.
When to talk with a clinician
Price is not the only variable in choosing a product or a dose. Ask which product and maintenance dose the clinician expects for you, then read that row of the tables above.
Frequently asked questions
How much is Wegovy without insurance?
Self-pay through NovoCare: $199 a month for the first two months at the starting doses (new patients, through 2026-12-31), then $349 for all pen doses through 2.4 mg, $399 for Wegovy HD; tablets $149 to $299 by dose. The list price is $1,349.02.
How much is Zepbound without insurance?
Through LillyDirect: $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 to 15 mg if you refill within 45 days; $499 to $699 otherwise. The list price is $499 to $1,086.37 per fill.
Is TrumpRx cheaper than the manufacturer?
No. TrumpRx.gov lists the manufacturers' own self-pay offers and routes Lilly products to LillyDirect. Same prices, same conditions.
Can I get Wegovy or Zepbound free through a patient-assistance program?
Not as of August 2026: neither Novo Nordisk's PAP product list nor Lilly Cares includes the weight-loss GLP-1s.